DCGI approves advanced trials for Biological E. Limited’s COVID- 19 vaccine
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator ...
- Latest
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator ...
New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the ...
New Delhi: Indian Institute of Technology-Madras has launched a new programme to boost its women leadership with an endowment fund ...
New Delhi (India Science Wire): The operation guidelines prepared by the Central Government for the COVID-19 vaccination programme currently underway, ...
New Delhi (India Science Wire): Considering that the highest level of political and administrative ownership, commitment, and support are needed ...
© 2022 Mharo Rajasthan
